Treatment for rare metabolic disease approved
FDA approved metreleptin for injection (Myalept, Amylin Pharmaceuticals) as replacement therapy to treat the complications of leptin deficiency, in addition to diet, in patients with congenital...
View ArticleFDA drug approvals: March 2014
Actions in brief Hyaluronate acid injection (Monovisc, Anika Therapeutics) was approved for the treatment of pain and improve joint mobility in patients with osteoarthritis of the knee. It is the...
View ArticleDrugs in Perspective: Myalept (metreleptin)
Lipodystrophy is an orphan disease. Only an estimated few thousand patients have this disease worldwide, although robust epidemiologic data are not available.1,2 Lipodystrophy is a group of chronic,...
View Article
More Pages to Explore .....
